This page lists all known medications that could potentially lead to 'Cerebral Vasospasm' as a side effect. It's important to note that mild side effects are quite common with medications. The ...

Jan. 20, 2005 (Phoenix) — Continuous intravenous magnesium infusion was associated with a decrease in cerebral vasospasm after subarachanoid hemorrhage, but there was no significant difference in ...

Results published in the Journal of Neurosurgery show that clazosentan significantly reduced the combined incidence of vasospasm-related morbidity and all-cause mortality post-aSAH with no unexpected ...

Sosei Group Corporation announces that Pivlaz (clazosentan sodium) 150 mg has received marketing approval from the Ministry of Food and Drug Safety (MFDS) in South Korea for the prevention of cerebral ...

This is a preview. Log in through your library . Abstract Using patient data obtained from the International Cooperative Aneurysm Study that evaluated clinical records from 68 neurosurgical centers in ...

CLINICAL, 1 angiographic 2 and experimental observations 3 indicate that the larger arteries of the brain, like other arteries of equivalent size, are capable of active vasospasm that may have serious ...

BOULDER, Colo., Jan. 11, 2012 /PRNewswire/ -- Clarimedix, Inc., a privately held company focused on the development of non-invasive therapeutics for the treatment of disorders associated with vascular ...

A Mayo Clinic research team is focusing on a hormone previously identified in the venom of the green mamba snake for the role it may play in a dangerous blood vessel narrowing in stroke patients that ...

The newly added report entitled Global Cerebral Vasospasm Market Size, Share, Growth, Industry Trends and Forecast to 2028 to the repository of Data Bridge Market Research features an extensive study ...

In this analysis, vasospasm-related DIND was reduced by 60% (p = 0.0004) and vasospasm-related new cerebral infarcts were reduced by 55% (p<0.0001). The studies confirmed the well-documented safety ...